The purpose of this survey is to
collect updated insights on consumer experiences with and attitudes
towards direct-to-consumer (DTC) promotion of prescription drugs.
This study will build on previous research by recruiting a wider
range of respondents, weighting the data to make it nationally
representative, and asking a wider range of questions about DTC
promotion, including in online formats. We will conduct a pilot
survey with 35 respondents and the main survey with 1,765
respondents. We plan to use an address-based mixed-mode methodology
that will direct one randomly-chosen member of sampled households
to complete a 20-minute online survey, with non-respondents
receiving a paper questionnaire. We will also conduct a
within-survey experiment to test whether a short statement
mentioning the previously paid incentive increases survey response,
thereby testing whether social exchange can be extended past the
initial contact attempt.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.